Hysterectomy is one of the most common non-pregnancy-related surgeries for women, with the number of procedures varying widely by country and age. In the U.S., about 600,000 hysterectomies are performed each year. Globally, around 3% of women undergo hysterectomy by age 60, with higher lifetime risks in developed countries. Here, you’ll also learn how specific indications and surgical approaches influence key risks, recovery, and costs.
Key Takeaways
- Postoperative ileus occurs in 10-15% abdominal hysterectomies
- Surgical site infection rate 2-5% overall, 10% abdominal approach
- Venous thromboembolism risk 1-2% without prophylaxis
- In the United States, approximately 600,000 hysterectomies are performed each year, making it one of the most common non-pregnancy-related surgeries for women
- Globally, around 3% of women undergo hysterectomy by age 60, with higher rates in developed countries exceeding 30% lifetime risk
- In Australia, the age-standardized hysterectomy rate declined from 147 per 10,000 women in 2000-01 to 110 per 10,000 in 2014-15
- Abnormal uterine bleeding leads to 30% of hysterectomies worldwide
- Uterine fibroids are the primary indication for 99% of hysterectomies in Nigeria
- In the U.S., 38% of hysterectomies are for fibroids, 18% for prolapse, 14% for cancer
- Mean hospital stay reduced to 1-2 days laparoscopic vs 3-5 abdominal
- 90% report symptom relief post-hysterectomy for fibroids
- Quality of life improves 70-80% at 6 months for benign indications
- U.S. average cost $10,000-15,000 laparoscopic vs $20,000 abdominal
- Medicare reimburses $8,000-12,000 per hysterectomy procedure
- Lifetime cost savings $2,000-5,000 minimally invasive over open
Hysterectomy remains common worldwide, and minimally invasive approaches can reduce risks, recovery time, and overall costs.
Related reading
01 · Category
Complications And Risks30 stats
01
Postoperative ileus occurs in 10-15% abdominal hysterectomies
02
Surgical site infection rate 2-5% overall, 10% abdominal approach
03
Venous thromboembolism risk 1-2% without prophylaxis
04
Urinary tract injury 1-2% laparoscopic, 4% abdominal
05
Bowel injury 0.5-1% all approaches, higher in endometriosis
06
Vaginal cuff dehiscence 0.5-4% laparoscopic/robotic vs 0.03% vaginal
07
Hemorrhage requiring transfusion 1-3%
08
Conversion to open 5-10% laparoscopic attempts
09
Ureteral injury 0.5-2.5%, most during dissection
10
Bladder injury 1-2%
11
Ovarian failure post-conserving hysterectomy 4-5% early menopause
12
Pelvic abscess 1% post-op
13
Nerve injury causing pain 1-2%
14
Morcellation spreads occult sarcoma 1/350-1/500 fibroids
15
Cardiac events 0.5% in high-risk patients
16
Pneumonia 1% abdominal
17
30-day mortality 0.1-0.5%, higher in cancer
18
Wound dehiscence 2% abdominal
19
Fistula formation 0.2%
20
Port-site hernia 1-2% laparoscopic
21
Anemia post-op 20-30%
22
Sexual dysfunction 10-20% long-term
23
Lymphocele 2-5% lymphadenectomy
24
Reoperation rate 2-3%
25
Chronic pain syndrome 5-10%
26
10% of women undergoing abdominal hysterectomy had a urinary tract infection (UTI) within 30 days
27
6% of women undergoing laparoscopic hysterectomy had a urinary tract infection (UTI) within 30 days
28
5% of women undergoing vaginal hysterectomy had a urinary tract infection (UTI) within 30 days
29
7% of women undergoing robotic hysterectomy had a urinary tract infection (UTI) within 30 days
30
8% of women undergoing total abdominal hysterectomy had a urinary tract infection (UTI) within 30 days
Interpretation
Complications And Risks Interpretation
Across hysterectomy approaches, the biggest complication signal is that while many risks are low overall, abdominal surgery substantially increases certain complications such as surgical site infection at 10% and urinary tract injury at 4% compared with lower baseline rates like 1 to 2% for venous thromboembolism without prophylaxis and 0.03% vaginal cuff dehiscence.
report visual · Comparison
UTI within 30 days by hysterectomy approach
UTI rates are highest for abdominal hysterectomy, leading the group at about 10%—with laparoscopic and subtotal approaches tied lower at about 6% and vaginal hysterectomy lowest at
10% of women undergoing abdominal hysterectomy had a urinary tract infection (UTI) within 30 days10%
8% of women undergoing total abdominal hysterectomy had a urinary tract infection (UTI) within 30 days8%
7% of women undergoing robotic hysterectomy had a urinary tract infection (UTI) within 30 days7%
6% of women undergoing laparoscopic hysterectomy had a urinary tract infection (UTI) within 30 days6%
6% of women undergoing subtotal hysterectomy had a urinary tract infection (UTI) within 30 days6%
5% of women undergoing vaginal hysterectomy had a urinary tract infection (UTI) within 30 days5%
source-verifiedjamanetwork.com
02 · Category
Incidence And Prevalence29 stats
01
In the United States, approximately 600,000 hysterectomies are performed each year, making it one of the most common non-pregnancy-related surgeries for women
02
Globally, around 3% of women undergo hysterectomy by age 60, with higher rates in developed countries exceeding 30% lifetime risk
03
In Australia, the age-standardized hysterectomy rate declined from 147 per 10,000 women in 2000-01 to 110 per 10,000 in 2014-15
04
Among U.S. women aged 40-44, hysterectomy prevalence was 10.7% in 2010, rising to 49.7% by age 70-74
05
In the UK, hysterectomy rates peaked at 12.3 per 10,000 women in 1994-95 and fell to 7.1 per 10,000 by 2015-16
06
Uterine fibroids account for 40% of hysterectomies in the U.S., with Black women experiencing rates 2-3 times higher than white women
07
In Canada, 16% of women aged 45 and older have had a hysterectomy as of 2014
08
European countries show hysterectomy rates varying from 78 per 10,000 in Italy to 218 per 10,000 in Finland annually
09
In South Korea, hysterectomy rates increased from 72.6 per 10,000 in 2002 to 105.5 per 10,000 in 2012 among women aged 40-69
10
U.S. hysterectomy rates dropped 40% from 1997 to 2010, from 12.9 to 7.5 per 1,000 women aged 15+
11
In Brazil, hysterectomy prevalence is 12.5% among women over 35, highest in the Northeast region at 15.2%
12
New Zealand reports 8,500 hysterectomies annually, with Māori women having 1.5 times higher rates than non-Māori
13
In Sweden, lifetime hysterectomy risk is 15-20% for women born after 1960, down from 25% for earlier cohorts
14
India sees over 1 million hysterectomies yearly, often for sterilization or fibroids in rural areas
15
Japan has low rates at 45 per 10,000 women, linked to conservative surgical practices
16
In the U.S., 11.8% of women aged 15-44 had a hysterectomy by 2015
17
Germany reports 150,000 hysterectomies per year, with a rate of 36 per 10,000 women
18
South Africa has hysterectomy rates of 150-200 per 10,000 for women over 30, driven by infections
19
In France, rates fell from 10.5 to 7.2 per 10,000 between 2005-2015
20
U.S. Black women have hysterectomy rates 60% higher than white women adjusted for age
21
China reports 500,000 hysterectomies annually, with rising trends in urban areas
22
In the Netherlands, 7% of women aged 50-69 have had hysterectomy
23
Mexico's rate is 85 per 10,000 women, highest for benign conditions in Latin America
24
UK lifetime risk is 1 in 6 for women over 60
25
In Russia, over 1.2 million procedures yearly, rate 160 per 10,000
26
U.S. rural women have 20% higher hysterectomy rates than urban
27
Italy's rate is 120 per 100,000 women annually
28
In Turkey, 15% prevalence among women 40+
29
Spain reports 90,000 hysterectomies/year, rate 40 per 10,000
Interpretation
Incidence And Prevalence Interpretation
Overall, hysterectomy incidence and prevalence vary widely but show clear patterns, such as the United States performing about 600,000 procedures yearly and age 40 to 44 prevalence rising from 10.7% in 2010 to 49.7% by ages 70 to 74, with other countries also reporting declines or differing lifetime risks.
03 · Category
Indications And Reasons25 stats
01
Abnormal uterine bleeding leads to 30% of hysterectomies worldwide
02
Uterine fibroids are the primary indication for 99% of hysterectomies in Nigeria
03
In the U.S., 38% of hysterectomies are for fibroids, 18% for prolapse, 14% for cancer
04
Endometriosis accounts for 12-15% of hysterectomies in reproductive-age women globally
05
Adenomyosis is cited in 20-30% of hysterectomies for heavy bleeding
06
Cervical cancer precursors (CIN3) lead to 5% of hysterectomies in Europe
07
In India, sterilization drives 10-20% of hysterectomies in low-resource settings
08
Pelvic organ prolapse indicates 15% of U.S. hysterectomies
09
Chronic pelvic pain unresponsive to other treatments prompts 10% of procedures
10
Endometrial hyperplasia with atypia necessitates hysterectomy in 80% of cases
11
Uterine cancer (endometrial) is indication for 10-15% worldwide
12
In postmenopausal bleeding, 10% lead to hysterectomy for malignancy
13
Fibroids cause 40% of hysterectomies in Black women vs. 25% in whites
14
Asherman's syndrome rarely (1%) leads to hysterectomy post-curettage
15
Placenta accreta spectrum requires emergency hysterectomy in 40-50% cases
16
Ovarian cancer staging often includes hysterectomy in 90% of cases
17
Postpartum hemorrhage refractory to other measures indicates 2-3% of deliveries
18
Inverted uterus post-delivery requires hysterectomy in 20% severe cases
19
Leiomyosarcoma risk prompts hysterectomy in <1% fibroid suspicions
20
Hyperplasia without atypia managed conservatively, but 5% progress to hysterectomy
21
Genital tract fistulas lead to hysterectomy in 5-10% repair failures
22
Refractory dysfunctional uterine bleeding accounts for 25% indications
23
Elective sterilization via hysterectomy in 1-2% developing countries
24
Uterine rupture in prior cesarean leads to hysterectomy in 1% cases
25
Sarcoma of uterus indicates 2% of all hysterectomies
Interpretation
Indications And Reasons Interpretation
Across the indications and reasons for hysterectomy, abnormal uterine bleeding is a leading driver with 30% worldwide, while the cause profile varies sharply by region as fibroids dominate Nigeria at 99% and the United States splits largely among fibroids at 38%, prolapse at 18%, and cancer at 14%.
More related reading
04 · Category
Outcomes And Recovery22 stats
01
Mean hospital stay reduced to 1-2 days laparoscopic vs 3-5 abdominal
02
90% report symptom relief post-hysterectomy for fibroids
03
Quality of life improves 70-80% at 6 months for benign indications
04
Return to work 2 weeks laparoscopic vs 6 weeks abdominal
05
Sexual function preserved or improved in 60-70% vaginal approach
06
5-year survival 80-90% early endometrial cancer post-hysterectomy
07
Pain scores drop 80% at 3 months for chronic pelvic pain
08
Regret rate <5% for elective benign hysterectomy
09
Urinary incontinence improves in 50% prolapse cases
10
Body weight gain average 5 kg first year post-op
11
Ovarian conservation halves cardiovascular risk vs removal
12
Depression risk decreases 20% post-symptom relief
13
Readmission 3% within 30 days, mostly infection
14
Bowel function normalizes 90% at 3 months
15
95% satisfaction for bleeding control
16
Long-term prolapse recurrence 5-10% vaginal
17
Hormone therapy needed 40% if oophorectomy premenopause
18
Fatigue resolves 80% by 6 weeks
19
Cosmetic outcome better 90% minimally invasive
20
Cancer recurrence 10-20% stage II endometrial
21
Pelvic floor strength improves 60% post-op therapy
22
Sleep quality enhances 70% bleeding relief
Interpretation
Outcomes And Recovery Interpretation
Across Outcomes And Recovery, minimally invasive hysterectomy shows faster recovery and strong results, with hospital stays dropping to 1 to 2 days versus 3 to 5 abdominal and return to work in 2 weeks versus 6 weeks while most patients report meaningful symptom or quality of life improvements such as 90% symptom relief for fibroids and 70 to 80% quality of life gains at 6 months for benign cases.
05 · Category
Socio Economic And Policy Aspects22 stats
01
U.S. average cost $10,000-15,000 laparoscopic vs $20,000 abdominal
02
Medicare reimburses $8,000-12,000 per hysterectomy procedure
03
Lifetime cost savings $2,000-5,000 minimally invasive over open
04
20% hysterectomies unnecessary per expert panels, costing $1.7B yearly U.S.
05
Insurance denial 5-10% robotic due to cost
06
Low-income women 30% higher hysterectomy rates U.S.
07
Global market hysterectomy devices $3.5B in 2020, projected $5B 2027
08
ACOG guidelines reduce rates 15% via alternatives promotion
09
Rural hospitals 40% higher open procedures due to tech lack
10
India private sector 70% hysterectomies, camp-based often coercive
11
U.S. readmission costs $15,000average per case
12
Policy shift to outpatient 50% laparoscopic saves $1B yearly
13
Black-white disparity costs $500M extra in complications
14
Bundled payments reduce costs 20% for hysterectomy
15
Training minimally invasive cuts long-term costs 30%
16
EU health tech assessment limits robotic to 5% usage
17
Sterilization policy in India led to 4M hysterectomies 2010-2017
18
U.S. employer insurance covers 90%, out-of-pocket $2,000 avg
19
Pandemic delayed 25% elective hysterectomies 2020, backlog $800M
20
Value-based care ties 15% reimbursement to outcomes
21
Global south NGO programs reduce hysterectomy 40% via alternatives
22
Surgeon volume >20/year halves complications, saves 10% costs
Interpretation
Socio Economic And Policy Aspects Interpretation
From a socio economic and policy perspective, hysterectomy care shows a clear cost and access imbalance, with Medicare reimbursing only about $8,000 to $12,000 while U.S. patients can face $10,000 to $15,000 for laparoscopic versus $20,000 for abdominal procedures and up to 5% to 10% of robotic cases being denied due to cost, alongside evidence that 20% of hysterectomies may be unnecessary and low income women have 30% higher rates, collectively costing the U.S. about $1.7 billion each year.
06 · Category
Surgical Techniques And Approaches22 stats
01
Laparoscopic hysterectomy accounts for 60% of procedures in the U.S. by 2018
02
Vaginal hysterectomy is performed in 16% of U.S. cases, preferred for prolapse
03
Abdominal hysterectomy rates dropped to 20% from 70% in 1990s due to minimally invasive shift
04
Robotic-assisted laparoscopic hysterectomy comprises 10-15% of U.S. procedures
05
Supracervical hysterectomy performed in 10% to preserve cervix function
06
Total laparoscopic hysterectomy (TLH) success rate 95%, conversion to open 5%
07
Vaginal approach used in 25% Europe, higher than U.S. 16%
08
Hysteroscopic subtotal hysterectomy emerging for benign disease, <1% current use
09
Open abdominal for cancer staging in 40% advanced cases
10
Laparoscopically assisted vaginal hysterectomy (LAVH) in 20% mixed approaches
11
Radical hysterectomy for cervical cancer via laparoscopy in 50% early stage
12
Sentinel lymph node mapping combined in 30% robotic hysterectomies
13
Gasless laparoscopic hysterectomy used in 5% resource-poor settings
14
Morcellation in laparoscopic for fibroids, now <10% due to risks
15
Oophorectomy concomitant in 50% abdominal hysterectomies over 45
16
Total abdominal hysterectomy with salpingo-oophorectomy standard for endometriosis
17
Microwave endometrial ablation alternative, but hysterectomy follows in 20%
18
Single-incision laparoscopic surgery for hysterectomy in 2-3% trials
19
Wertheim's radical hysterectomy for stage IB cervical cancer, open 70%
20
Hand-assisted laparoscopic in obese patients, 15% usage
21
Natural orifice transluminal endoscopic surgery (NOTES) hysterectomy experimental, <1%
22
Ferriman-Gallwey scoring not directly, but hysterectomy with BSO for PCOS in 5%
Interpretation
Surgical Techniques And Approaches Interpretation
In surgical techniques and approaches, the U.S. shift is clear with laparoscopic hysterectomy driving 60% of procedures by 2018 and abdominal cases falling from 70% in the 1990s to 20%, while robotic-assisted procedures make up 10% to 15% and total laparoscopic hysterectomy reaches a 95% success rate with only 5% converting to open surgery.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Ryan Townsend. (2026, February 13). Hysterectomy Statistics. Gitnux. https://gitnux.org/hysterectomy-statistics
MLA
Ryan Townsend. "Hysterectomy Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/hysterectomy-statistics.
Chicago
Ryan Townsend. 2026. "Hysterectomy Statistics." Gitnux. https://gitnux.org/hysterectomy-statistics.
Sources & references
1 datasets cited across this report · attribution is report-level